Increased ACE2, sRAGE, and immune activation, but lowered calcium and magnesium in COVID-19.

Hussein Kadhem Al-HakeimHawraa Kadhem Al-JassasGerwyn MorrisMichael Maes

Published in: Recent advances in inflammation & allergy drug discovery (2022)

The results show that immune-inflammatory and RAGE pathways biomarkers may be used as external validating criterion for the diagnosis COVID-19. Those pathways coupled with lowered SpO2, calcium and magnesium are drug targets that may help to reduce the consequences of COVID-19.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
angiotensin ii
drug induced
adverse drug